BASILEA
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

BASILEA Trademark

Serial Number: 97876573

BASILEA is a trademark filed by BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL on April 6, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (18 trademarks)

HEGENHEIMERMATTWEG 167B
ALLSCHWIL 4123 , CH

Entity Type: 03

Trademark Details

Filing Date

April 6, 2023

Registration Date

Not Registered

Published for Opposition

February 13, 2024

Goods & Services

Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of allergies; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical clinical purposes; clinical medical reagents; all of the aforesaid for prescription only

Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions and for the treatment of infections and diseases; chemical substances for use in research and development of pharmaceuticals for the treatment of dermatological conditions and for the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use

Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 1, 2025 EXRA
SOU EXTENSION 3 GRANTED
Oct 1, 2025 EX3G
SOU EXTENSION 3 FILED
Sep 30, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 30, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 28, 2025 EXRA
SOU EXTENSION 2 GRANTED
Mar 28, 2025 EX2G
SOU EXTENSION 2 FILED
Mar 27, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 27, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 4, 2024 EXRA
SOU EXTENSION 1 GRANTED
Oct 4, 2024 EX1G
SOU EXTENSION 1 FILED
Oct 4, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 4, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 9, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 13, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 13, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 4, 2024 CNSA
ASSIGNED TO EXAMINER
Jan 2, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 2, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 1, 2023 NWOS
NEW APPLICATION ENTERED
Apr 10, 2023 NWAP